annual accounts payable:
$2.29M-$9.28M(-80.20%)Summary
- As of today (September 16, 2025), XERS annual accounts payable is $2.29 million, with the most recent change of -$9.28 million (-80.20%) on December 31, 2024.
- During the last 3 years, XERS annual accounts payable has fallen by -$6.63 million (-74.34%).
- XERS annual accounts payable is now -80.20% below its all-time high of $11.56 million, reached on December 31, 2023.
Performance
XERS Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$9.46M+$3.11M(+48.96%)Summary
- As of today (September 16, 2025), XERS quarterly accounts payable is $9.46 million, with the most recent change of +$3.11 million (+48.96%) on June 30, 2025.
- Over the past year, XERS quarterly accounts payable has increased by +$3.66 million (+63.19%).
- XERS quarterly accounts payable is now -21.66% below its all-time high of $12.08 million, reached on September 30, 2023.
Performance
XERS quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
XERS Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -80.2% | +63.2% |
| 3 y3 years | -74.3% | +42.7% |
| 5 y5 years | -59.1% | +113.1% |
XERS Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.2% | at low | -21.7% | +313.2% |
| 5 y | 5-year | -80.2% | at low | -21.7% | +313.2% |
| alltime | all time | -80.2% | +164.4% | -21.7% | +1601.8% |
XERS Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $9.46M(+49.0%) |
| Mar 2025 | - | $6.35M(+177.4%) |
| Dec 2024 | $2.29M(-80.2%) | $2.29M(-69.3%) |
| Sep 2024 | - | $7.45M(+28.5%) |
| Jun 2024 | - | $5.80M(-18.3%) |
| Mar 2024 | - | $7.09M(-38.7%) |
| Dec 2023 | $11.56M(+151.1%) | $11.56M(-4.2%) |
| Sep 2023 | - | $12.08M(+3.9%) |
| Jun 2023 | - | $11.62M(-3.0%) |
| Mar 2023 | - | $11.98M(+160.2%) |
| Dec 2022 | $4.61M(-48.4%) | $4.61M(+17.6%) |
| Sep 2022 | - | $3.92M(-40.9%) |
| Jun 2022 | - | $6.63M(-40.2%) |
| Mar 2022 | - | $11.09M(+24.3%) |
| Dec 2021 | $8.92M | $8.92M(+108.0%) |
| Sep 2021 | - | $4.29M(-17.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $5.18M(+8.7%) |
| Mar 2021 | - | $4.77M(+53.0%) |
| Dec 2020 | $3.12M(-44.4%) | $3.12M(-33.6%) |
| Sep 2020 | - | $4.69M(+5.7%) |
| Jun 2020 | - | $4.44M(+15.6%) |
| Mar 2020 | - | $3.84M(-31.5%) |
| Dec 2019 | $5.60M(+547.0%) | $5.60M(+233.9%) |
| Sep 2019 | - | $1.68M(-8.8%) |
| Jun 2019 | - | $1.84M(+30.7%) |
| Mar 2019 | - | $1.41M(+62.6%) |
| Dec 2018 | $866.00K(-56.2%) | $866.00K(+39.2%) |
| Sep 2018 | - | $622.00K(+11.9%) |
| Jun 2018 | - | $556.00K(-34.4%) |
| Mar 2018 | - | $847.00K(-57.1%) |
| Dec 2017 | $1.98M(+50.3%) | $1.98M |
| Dec 2016 | $1.31M | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual accounts payable?
- What is the all time high annual accounts payable for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual accounts payable year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly accounts payable year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual accounts payable?
The current annual accounts payable of XERS is $2.29M
What is the all time high annual accounts payable for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual accounts payable is $11.56M
What is Xeris Biopharma Holdings, Inc. annual accounts payable year-on-year change?
Over the past year, XERS annual accounts payable has changed by -$9.28M (-80.20%)
What is Xeris Biopharma Holdings, Inc. quarterly accounts payable?
The current quarterly accounts payable of XERS is $9.46M
What is the all time high quarterly accounts payable for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly accounts payable is $12.08M
What is Xeris Biopharma Holdings, Inc. quarterly accounts payable year-on-year change?
Over the past year, XERS quarterly accounts payable has changed by +$3.66M (+63.19%)